Kerala Ayurveda Limited is an ayurveda company. The Company is engaged in providing ayurvedic services and products. It provides healing and wellness solutions. The Company classifies its products into three categories: Proprietary Products, Classical Products and Consumer Products. Its product categories include diabetes/heart health, hair care, child/kids health, women care, men's care, gastro care, respiratory and allergy, general health/immunity, massage oils, renal care and joint care. Its manufacturing facility produces a range of approximately 350 Classical and Proprietary Ayurvedic medicines, including therapeutic formulations. Its resort, hospitals, wellness centers and clinics offer a range of ayurveda lifestyle products, including health supplements, skin and beauty care products and specialty foods. The Company exports its products to various countries, including the United States, Japan, Australia, the United Kingdom, Switzerland, Canada, Vienna (Austria) and Denmark.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.